Skip to main content
Journal of Hematology & Oncology logoLink to Journal of Hematology & Oncology
. 2025 Mar 18;18:31. doi: 10.1186/s13045-025-01685-3

Correction: myCAF-derived Exosomal PWAR6 accelerates CRC liver metastasis via altering glutamine availability and NK cell function in the tumor microenvironment

Hongsheng Fang 1,2, Weixing Dai 1,2, Ruiqi Gu 1,2, Yanbo Zhang 1,2, Jin Li 1,2, Wenqin Luo 1,2, Shanyou Tong 2,3, Lingyu Han 1,2, Yichao Wang 1,2, Chengyao Jiang 1,2, Xue Wang 4,, Renjie Wang 1,2,, Guoxiang Cai 1,2,
PMCID: PMC11921548  PMID: 40102959

Correction: Journal of Hematology & Oncology (2024) 17:126

10.1186/s13045-024-01643-5

The authors wish to note two corrections to errors in Figure 7F (LvPWAR6 group) and Supplementary Figure 3D (DLD1/myCAFs group, transwell assay). The authors sincerely apologize for one incorrect image for Figure 7F and one incorrect image for Supplementary Figure 3D which had been inadvertently included in the originally published article.

After carefully reviewing the original experimental records and raw data, the authors confirm that they were both unintentional errors. The authors would like to emphasize that these two errors do not impact the scientific conclusions of the article. In addition, the authors have also carefully reviewed the other raw data and did not find any other errors in the published article.

The authors provide the corrected images for the Figure 7F and Supplementary Figure 3D as below.

Fig. 1.

Fig. 1

Corrected Figure 7F

Fig. 2.

Fig. 2

Corrected Supplementary Figure 3D

Footnotes

The online version of the original article can be found at 10.1186/s13045-024-01643-5.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Xue Wang, Email: wangxuefghc@163.com.

Renjie Wang, Email: wangbladejay@sina.com.

Guoxiang Cai, Email: gxcaifuscc@163.com.


Articles from Journal of Hematology & Oncology are provided here courtesy of BMC

RESOURCES